SWK Holdings Corp

SWK Holdings Corp is a U.S.-based specialty finance company that provides asset-backed lending and royalty financing to healthcare and life sciences businesses. Its portfolio includes senior secured debt, revenue-interest financings, royalty purchases, and related investment positions, with operations organized around finance receivables and pharmaceutical development.

49,0 %

−6,1 %

−7,8 %

9.41

9.41

— SWK Holdings Corp
%
Finance Receivables80% Senior secured loans and revenue-interest assets repaid from borrower cash flows, net sales, or royalties.
Royalty Purchases10% Purchased royalty streams tied to licensed pharmaceutical and medical technology products.
Pharmaceutical Development5% Development-stage pharmaceutical assets and related manufacturing or R&D activities.
Marketable Investments and Warrants5% Minority investments, warrant assets, and other equity-linked positions in portfolio companies.

SWK primarily finances healthcare, pharmaceutical, and medical technology companies that need non-dilutive capital tied...

  • Healthcare and life sciences borrowersprimary

    Companies that borrow against product revenues, royalties, or other secured assets to fund operations and growth.

  • Royalty sellers and licensorsprimary

    Owners of pharmaceutical or medical product royalty streams that sell future cash flows for upfront capital.

  • Medical technology and specialty pharma counterpartiessecondary

    Businesses whose product sales generate the revenue interests and royalties that support SWK's assets.

  • Equity and warrant counterpartiessecondary

    Portfolio companies where SWK holds warrants or equity-linked positions alongside debt or royalty assets.

SWK is headquartered in the United States and its portfolio is primarily tied to U.S. healthcare and life sciences...

  • •Headquartered in the United States
  • •Portfolio concentrated in U.S. healthcare and life sciences
  • •Some royalty exposure to international sales
  • •No country-level revenue split disclosed in excerpts
  • •Geography affects borrower sales and royalty collections

SWK's strategy centers on originating structured healthcare financings and royalty assets that generate contractual...

01
Expand structured healthcare lendingmedium-term

This is the core source of contractual cash flow and portfolio growth.

02
Grow royalty and revenue-interest assetsmedium-term

Royalty streams diversify returns beyond traditional lending and can provide long-duration cash flows.

03
Actively manage portfolio exits and monetizationsshort-term

Payoffs, sales, and conversions recycle capital and reduce concentration in aging positions.

SWK is exposed to credit risk, borrower performance risk, and valuation risk because its assets are repaid from...

high

Credit deterioration in portfolio companies

Repayment depends on borrower sales, royalties, and operating performance.

Scope
Finance receivables and royalty assets
Materiality
high
high

Interest-rate and funding spread risk

Borrowing costs can rise faster than asset yields on floating/fixed mix portfolios.

Scope
Revolving credit facility and leveraged investments
Materiality
high
high

Concentration in healthcare and life sciences assets

A small number of specialized counterparties can drive a large share of returns.

Scope
Royalty purchases and secured loans
Materiality
high
medium

Fair value volatility on investments and warrants

Market and company-specific changes affect unrealized gains/losses and carrying values.

Scope
Warrant assets, marketable investments, impaired positions
Materiality
medium
medium

Inflation pressure on partner companies

Higher input costs can reduce borrower profitability and repayment capacity.

Scope
Portfolio companies with limited pricing power
Materiality
medium
Fair value measurement
Can create unrealized gains or losses and change net asset value
Revenue recognition on royalties and revenue interests
Can cause uneven quarterly revenue and comparability issues
Non-accrual and impairment
Directly affects interest income and asset carrying values
Held-for-sale accounting
Changes balance sheet mix and can affect reported revenue timing

SS&C Technologies Holdings Inc

SSNC · Services-Prepackaged Software

Scienture Holdings, Inc.

SCNX · Pharmaceutical Preparations

SHF Holdings, Inc.

SHFS · Finance Services

SCWorx Corp.

WORX · Services-Computer Processing & Data Preparation

SelectQuote, Inc.

SLQT · Insurance Agents, Brokers & Service

Royalty Pharma plc

RPRX · Pharmaceutical Preparations

: 29/04/2026